Home » NASAL SPRAY PITCHED FOR BRITTLE BONES
NASAL SPRAY PITCHED FOR BRITTLE BONES
A Washington state-based pharmaceutical company will let Procter & Gamble
Co. develop and market its nasal spray for treatment of osteoporosis, the companies
said Wednesday. Nastech Pharmaceutical Company Inc. of Bothell, Wash., said
it will grant P&G rights to the worldwide development and commercialization
of its parathyroid hormone nasal spray. Terms of the deal include a $10 million
initial payment, with additional goal-based payments that could reach $577 million
over the life of the agreement.
The
Daily News Online
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May